HMy2 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HMy2 cell line is a human B lymphoblastoid cell line derived from an adult individual. This cell line was originally established for the study of human B cell function, lymphoma, and immunological responses. The HMy2 cells are commonly used in research due to their capacity to produce a wide range of immunoglobulins and cytokines, which makes them an excellent model for investigating B cell activation, differentiation, and the molecular mechanisms underlying lymphoid malignancies. HMy2 cells exhibit typical characteristics of B lymphoblastoid cells, such as a high nuclear-to-cytoplasmic ratio and the presence of surface markers indicative of B cell lineage, including CD19 and CD20. These cells are also known to express HLA-DR antigens, making them suitable for studies related to antigen presentation and immune response modulation. Researchers often utilize HMy2 cells in experiments involving gene expression, transfection, and hybridoma technology, contributing to advancements in therapeutic antibody development and cancer immunotherapy. |
|---|---|
| Organism | Human |
| Tissue | Hematopoietic |
| Disease | Plasma cell leukemia |
| Applications | Hybridoma fusion partner, Analysis of B cell surface antigens, testing of cytotoxic drugs, mutational analysis, analysis of apoptotic mechanisms, HLA-standard. |
| Synonyms | LICR-Lon-HMy-2, LICR-LON-HMy2, LICR.LON.HMy2, Licr.Lon.Hmy2, LICRLON/My2, HMy.2 B, LICR-2 |
Characteristics
| Age | 33 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Round cells |
| Cell type | Lymphoblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | HMy2 (Cytion catalog number 302008) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_8119 |
Biomolecular Data
| Karyotype | 46, hypodiploid |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Seeding density | 1 x 105 cells/mL |
| Fluid renewal | Every 3 to 5 days |
| Post-Thaw Recovery | Fast |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 302008-119 | Certificate of Analysis | 23. May. 2025 | 302008 |